The Global Oxytocic Pharmaceutical Market is expected to be around US$ 10.40 Billion by 2028 at a CAGR of 9.3% in the given forecast period.
Accessible under the brand name of Pitocin, the medication oxytocin, which is gotten from the peptide of a similar name, is regularly utilized on ladies during labor so as to initiate constrictions. This cannot just expand work speeds and diminish the time taken for labor, yet can likewise stop seeping after conveyance. It is quite often regulated to a patient by infusing it into their vein or muscle.
Rising instances of pregnancy-related confusions, Expanding the number of caesarian methods, Extension of social insurance and pharmaceutical ventures, Expanding frequency of preterm births and the rising paces of work enlistment, Symptoms identified with oxytocic tranquilize are some of the factors help to drive the market growth.
The global Oxytocic Pharmaceutical market is segregated on the basis of Product as Natural Oxytocin and Synthetic Oxytocin Derivative. Based on End User the global Oxytocic Pharmaceutical market is segmented in Hospitals and Maternity Clinics.
The global Oxytocic Pharmaceutical market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Oxytocic Pharmaceutical market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Fresenius Kaci, Biofutura, Baxter Healthcare, Pfizer, Ferring, Novartis, Teva Pharmaceutical Industries, and others are among the major players in the global Oxytocic Pharmaceutical market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Oxytocic Pharmaceutical Market has been segmented as below:
Oxytocic Pharmaceutical Market, By Product
Oxytocic Pharmaceutical Market, By End User
Oxytocic Pharmaceutical Market, By Region
Oxytocic Pharmaceutical Market, By Company
The report covers:
Report Scope:
The global Oxytocic Pharmaceutical market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Oxytocic Pharmaceutical market share. Major industry players with significant revenue share include Fresenius Kaci, Biofutura, Baxter Healthcare, Pfizer, Ferring, Novartis, Teva Pharmaceutical Industries, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Oxytocic Pharmaceutical Market, By Product
5.1 Introduction
5.2 Natural Oxytocin
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Synthetic Oxytocin Derivative
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6. Oxytocic Pharmaceutical Market, By End User
6.1 Introduction
6.2 Hospitals
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Maternity Clinics
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Oxytocic Pharmaceutical Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Oxytocic Pharmaceutical, By Product
7.2.2 North America Oxytocic Pharmaceutical, By End User
7.3 Europe
7.3.1 Europe Oxytocic Pharmaceutical, By Product
7.3.2 Europe Oxytocic Pharmaceutical, By End User
7.4 Asia-Pacific
7.4.1 Asia-Pacific Oxytocic Pharmaceutical, By Product
7.4.2 Asia-Pacific Oxytocic Pharmaceutical, By End User
7.5 Rest of the World
7.5.1 Rest of the World Oxytocic Pharmaceutical, By Product
7.5.2 Rest of the World Oxytocic Pharmaceutical, By End User
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Fresenius Kaci
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 BioFutura
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Baxter Healthcare
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Pfizer
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Ferring
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Novartis
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Teva Pharmaceutical Industries
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
The Oxytocic Pharmaceutical Market has been segmented as below:
Oxytocic Pharmaceutical Market, By Product
Oxytocic Pharmaceutical Market, By End User
Oxytocic Pharmaceutical Market, By Region
Oxytocic Pharmaceutical Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
